Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit
Niki Dermitzaki, Foteini Balomenou, Dimitra Gialamprinou, Vasileios Giapros, Dimitrios Rallis, Maria Baltogianni, Célia Fortuna Rodrigues · 2024
Read Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit by Niki Dermitzaki, Foteini Balomenou, Dimitra Gialamprinou, Vasileios Giapros, Dimitrios Rallis, Maria Baltogianni, Célia Fortuna Rodrigues (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11672459.txt.
Description
Niki Dermitzaki and co-authors review the use of echinocandin antifungals in newborn intensive care, where invasive Candida infections strike fragile babies. Low birth weight and critical illness raise the risk sharply. These infections carry high death rates and lasting harm.
Fast, well-chosen treatment improves survival in these cases. The usual first-line drugs do not always fit the child. Strain, infection depth, and prior prevention all shape the choice. Implanted devices add another layer of risk to weigh. The review gathers evidence on three echinocandin drugs. Dosing, safety, and success data in neonates are compared. The authors map when these alternatives make sense. The piece guides clinicians facing resistant infections.
Catalog record
| CREATOR | Niki Dermitzaki, Foteini Balomenou, Dimitra Gialamprinou, Vasileios Giapros, Dimitrios Rallis, Maria Baltogianni, Célia Fortuna Rodrigues |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |